Anti-hyperlipidemic activity of Withania coagulans in streptozotocin-induced diabetes: A potent anti-atherosclerotic agent.

Abstract

Dyslipidemia is one of the most common complications in diabetes mellitus, which increases risk of premature atherosclerosis. Drugs having antihyperlipidemic activity in addition to their hypoglycemic effect in diabetes may be suitable anti-atherosclerotic agents in diabetic patients. The present study was aimed to investigate the anti-atherosclerotic… (More)

Topics

6 Figures and Tables

Cite this paper

@article{Saxena2010AntihyperlipidemicAO, title={Anti-hyperlipidemic activity of Withania coagulans in streptozotocin-induced diabetes: A potent anti-atherosclerotic agent.}, author={Bhagawati Saxena}, journal={Drug discoveries & therapeutics}, year={2010}, volume={4 5}, pages={334-40} }